DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Ottawa Marriott Hotel

2016 年 10 月 18 日 8:00 上午 - 2016 年 10 月 19 日 4:00 下午

100 Kent Street , Ottawa, ON K1P5R7 , CANADA

DIA Annual Canadian Meeting 2016

Explore how innovation can support new initiatives, regulatory processes, research, transparency, engagement, personalized medicine, and use of real-world data in Canada.

Session 2 Plenary Session: Setting Strategic Direction - A View from the Regulators and Industry

Session Chair(s)

Marilena  Bassi, MA

Marilena Bassi, MA

Senior Executive Director, Therapeutic Products Directorate

Health Canada, Canada

Senior leaders from both government and industry will discuss renewal and strategic priority setting within their respective organizations. You will have the opportunity to learn about the future directions of these key organizations, their priorities for the coming years, and how each is evolving and changing to be better positioned to meet emerging trends and issues. There will be an opportunity to ask questions and explore the concepts in more detail.

Speaker(s)

Deirdre  Cozier

Session Co-Chair

Deirdre Cozier

Pharmascience, Canada

Director, Global Regulatory Affairs

Brian  O'Rourke, PHARMD

Speaker

Brian O'Rourke, PHARMD

Canadian Agency for Drugs and Technologies in Health, Canada

President and Chief Executive Officer

Pierre  Sabourin, MBA

Speaker

Pierre Sabourin, MBA

Health Canada, Canada

Assistant Deputy Minister, Health Products and Food Branch

Keith  McIntosh

Speaker

Keith McIntosh

Innovative Medicines Canada, Canada

Executive Director, Scientific & Regulatory Affairs

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。